Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bingley, P. J.
Right arrow Articles by Gale, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bingley, P. J.
Right arrow Articles by Gale, E. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 11 1701-1710, Copyright © 1997 by American Diabetes Association

ARTICLES

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

PJ Bingley, E Bonifacio, AJ Williams, S Genovese, GF Bottazzo and EA Gale
Department of Medicine, the University of Bristol, U.K.

Strategies for assessing risk of progression to IDDM, based on single and combined autoantibody measurement, were evaluated in 2,855 schoolchildren (median age 11.4 years) and 256 children with newly diagnosed IDDM (median age 10.2 years), recruited to a population-based study in the Oxford region. In 256 children with IDDM, levels of antibodies > or =97.5th centile of the schoolchild population were found in 225 (88%) for islet cell antibodies (ICAs), in 190 (74%) for antibodies to GAD, in 193 (75%) for antibodies to protein tyrosine phosphatase IA-2 (IA-2), and in 177 (69%) for autoantibodies to insulin (IAAs). Estimates of risk of progression to IDDM within 10 years, derived by comparing the distribution of antibody markers in the two populations (schoolchildren and children with IDDM), were 6.7% (ICAs), 6.6% (GAD antibodies), 5.6% (IA-2 antibodies), and 4.8% (IAAs) for schoolchildren with levels above the 97.5th centile, increasing to 20, 23, 24, and 11%, respectively, for antibody levels >99.5th centile. Most children with IDDM had multiple antibody markers, and 89% of those diagnosed over age 10 years had > or =2 antibodies above the 97.5th centile, as compared against 0.7% of schoolchildren, in whom this combination gave a 27% 10-year estimated risk of IDDM. Risk increased but sensitivity fell as combined antibody thresholds were raised, or the number of antibodies above the threshold was increased. Strategies based on detection of > or =2 antibodies with primary testing for GAD and IA-2 antibodies and second line testing for ICAs and/or IAAs were evaluated. Detection of at least two markers selected from GAD antibodies > or =97.5th centile and/or IA-2 antibodies > or =99.5th centile and/or ICAs > or =97.5th centile identified 0.25% of schoolchildren and 83% of children with newly diagnosed IDDM, with an estimated risk of 71% (95% CI 57-91). Although confirmation from prospective studies is still needed, this analysis suggests that antibody combinations can predict diabetes in the general population.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Br Med BullHome page
K. L. Mehers and K. M. Gillespie
The genetic basis for type 1 diabetes
Br. Med. Bull., December 1, 2008; 88(1): 115 - 129.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Diamantopoulos, G. Allende, J. M. Ferreira, G. Ciancio, G. W. Burke, and A. Pugliese
Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors
Diabetes Care, September 1, 2008; 31(9): 1741 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Maruyama, S. Oak, A. Shimada, and C. S. Hampe
GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
Diabetes Care, August 1, 2008; 31(8): 1602 - 1607.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Tiberti, C. Giordano, M. Locatelli, E. Bosi, G. F. Bottazzo, R. Buzzetti, D. Cucinotta, A. Galluzzo, A. Falorni, and F. Dotta
Identification of Tyrosine Phosphatase 2(256-760) Construct as a New, Sensitive Marker for the Detection of Islet Autoimmunity in Type 2 Diabetic Patients: The Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 2
Diabetes, May 1, 2008; 57(5): 1276 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Oak, L. K. Gilliam, M. Landin-Olsson, C. Torn, I. Kockum, C. R. Pennington, M. J. Rowley, M. R. Christie, J. P. Banga, and C. S. Hampe
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
PNAS, April 8, 2008; 105(14): 5471 - 5476.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Wang, S. Jia, R. Geoffrey, R. Alemzadeh, S. Ghosh, and M. J. Hessner
Identification of a Molecular Signature in Human Type 1 Diabetes Mellitus Using Serum and Functional Genomics
J. Immunol., February 1, 2008; 180(3): 1929 - 1937.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. J. Bingley, J. L Mahon, E. A.M. Gale, and for the European Nicotinamide Diabetes Interventio
Insulin Resistance and Progression to Type 1 Diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)
Diabetes Care, January 1, 2008; 31(1): 146 - 150.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Blancou, R. Mallone, E. Martinuzzi, S. Severe, S. Pogu, G. Novelli, G. Bruno, B. Charbonnel, M. Dolz, L. Chaillous, et al.
Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients
J. Immunol., June 1, 2007; 178(11): 7458 - 7466.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Hampe, R. Nalini, M. R. Maldonado, T. R. Hall, G. Garza, D. Iyer, and A. Balasubramanyam
Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with {beta}-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 462 - 467.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Wang, D. Miao, S. Babu, J. Yu, J. Barker, G. Klingensmith, M. Rewers, G. S. Eisenbarth, and L. Yu
Prevalence of Autoantibody-Negative Diabetes Is Not Rare at All Ages and Increases with Older Age and Obesity
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 88 - 92.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. M. Gillespie, R. J. Dix, A. J.K. Williams, R. Newton, Z. F. Robinson, P. J. Bingley, E. A.M. Gale, and J. P.H. Shield
Islet Autoimmunity in Children With Down's Syndrome
Diabetes, November 1, 2006; 55(11): 3185 - 3188.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
K. M. Gillespie
Type 1 diabetes: pathogenesis and prevention.
Can. Med. Assoc. J., July 18, 2006; 175(2): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. L. Edghill, R. J. Dix, S. E. Flanagan, P. J. Bingley, A. T. Hattersley, S. Ellard, and K. M. Gillespie
HLA Genotyping Supports a Nonautoimmune Etiology in Patients Diagnosed With Diabetes Under the Age of 6 Months
Diabetes, June 1, 2006; 55(6): 1895 - 1898.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Gianani, A. Putnam, T. Still, L. Yu, D. Miao, R. G. Gill, J. Beilke, P. Supon, A. Valentine, A. Iveson, et al.
Initial Results of Screening of Nondiabetic Organ Donors for Expression of Islet Autoantibodies
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1855 - 1861.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. M. Barker
Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1210 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Sepa, A. Frodi, and J. Ludvigsson
Mothers' Experiences of Serious Life Events Increase the Risk of Diabetes-Related Autoimmunity in Their Children
Diabetes Care, October 1, 2005; 28(10): 2394 - 2399.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-i. Harashima, A. Clark, M. R. Christie, and A. L. Notkins
The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion
PNAS, June 14, 2005; 102(24): 8704 - 8709.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. Sparre, M. R. Larsen, P. E. Heding, A. E. Karlsen, O. N. Jensen, and F. Pociot
Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics: Present And Future Directions
Mol. Cell. Proteomics, April 1, 2005; 4(4): 441 - 457.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. M. Gillespie, R. Nolsoe, V. M. Betin, O. P. Kristiansen, P. J. Bingley, T. Mandrup-Poulsen, and E. A.M. Gale
Is Puberty an Accelerator of Type 1 Diabetes in IL6-174CC Females?
Diabetes, April 1, 2005; 54(4): 1245 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. L. Edghill, A. L. Gloyn, K. M. Gillespie, A. P. Lambert, N. T. Raymond, P. G. Swift, S. Ellard, E. A.M. Gale, and A. T. Hattersley
Activating Mutations in the KCNJ11 Gene Encoding the ATP-Sensitive K+ Channel Subunit Kir6.2 Are Rare in Clinically Defined Type 1 Diabetes Diagnosed Before 2 Years
Diabetes, November 1, 2004; 53(11): 2998 - 3001.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. M. Barker, K. J. Barriga, L. Yu, D. Miao, H. A. Erlich, J. M. Norris, G. S. Eisenbarth, and M. Rewers
Prediction of Autoantibody Positivity and Progression to Type 1 Diabetes: Diabetes Autoimmunity Study in the Young (DAISY)
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3896 - 3902.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. M. Barker, S. H. Goehrig, K. Barriga, M. Hoffman, R. Slover, G. S. Eisenbarth, J. M. Norris, G. J. Klingensmith, and M. Rewers
Clinical Characteristics of Children Diagnosed With Type 1 Diabetes Through Intensive Screening and Follow-Up
Diabetes Care, June 1, 2004; 27(6): 1399 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. S. Eisenbarth and P. A. Gottlieb
Autoimmune Polyendocrine Syndromes
N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
H. M. Stanley, J. M. Norris, K. Barriga, M. Hoffman, L. Yu, D. Miao, H. A. Erlich, G. S. Eisenbarth, and M. Rewers
Is Presence of Islet Autoantibodies at Birth Associated With Development of Persistent Islet Autoimmunity?: The Diabetes Autoimmunity Study in the Young (DAISY)
Diabetes Care, February 1, 2004; 27(2): 497 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. M Virtanen and M. Knip
Nutritional risk predictors of {beta} cell autoimmunity and type 1 diabetes at a young age
Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1053 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Ota, T. Takamura, Y. Bando, R. Usuda, and Y. Nagai
Predictive Value of Autoantibodies to IA-2 for Insulin Requirements in Japanese Subjects With Type 1 Diabetes
Diabetes Care, November 1, 2003; 26(11): 3188 - 3189.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
K. R. Owen, A. Stride, S. Ellard, and A. T. Hattersley
Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes
Diabetes Care, July 1, 2003; 26(7): 2088 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Hanifi-Moghaddam, N. C. Schloot, S. Kappler, J. Seissler, and H. Kolb
An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes
Diabetes, May 1, 2003; 52(5): 1137 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Gianani and G. S. Eisenbarth
Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1442 - 1444.
[Full Text] [PDF]

Home page
 PediatricsHome page
P. A. Offit and C. J. Hackett
Addressing Parents' Concerns: Do Vaccines Cause Allergic or Autoimmune Diseases?
Pediatrics, March 1, 2003; 111(3): 653 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
M A Kelly, M L Rayner, C H Mijovic, and A H Barnett
Molecular aspects of type 1 diabetes
Mol. Pathol., February 1, 2003; 56(1): 1 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. P. Lambert, S. Ellard, L. I.S. Allen, I. W. Gallen, K. M. Gillespie, P. J. Bingley, and A. T. Hattersley
Identifying Hepatic Nuclear Factor 1{alpha} Mutations in Children and Young Adults With a Clinical Diagnosis of Type 1 Diabetes
Diabetes Care, February 1, 2003; 26(2): 333 - 337.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. P. Krischer, D. D. Cuthbertson, L. Yu, T. Orban, N. Maclaren, R. Jackson, W. E. Winter, D. A. Schatz, J. P. Palmer, and G. S. Eisenbarth
Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 103 - 108.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Kimpimaki, P. Kulmala, K. Savola, A. Kupila, S. Korhonen, T. Simell, J. Ilonen, O. Simell, and M. Knip
Natural History of {beta}-Cell Autoimmunity in Young Children with Increased Genetic Susceptibility to Type 1 Diabetes Recruited from the General Population
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4572 - 4579.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
W. E. Winter, N. Harris, and D. Schatz
Immunological Markers in the Diagnosis and Prediction of Autoimmune Type 1a Diabetes
Clin. Diabetes, October 1, 2002; 20(4): 183 - 191.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. S. Coulson, P. D. Witterick, Y. Tan, M. J. Hewish, J. N. Mountford, L. C. Harrison, and M. C. Honeyman
Growth of Rotaviruses in Primary Pancreatic Cells
J. Virol., August 12, 2002; 76(18): 9537 - 9544.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Saeki, M. Zhu, A. Kubosaki, J. Xie, M. S. Lan, and A. L. Notkins
Targeted Disruption of the Protein Tyrosine Phosphatase-Like Molecule IA-2 Results in Alterations in Glucose Tolerance Tests and Insulin Secretion
Diabetes, June 1, 2002; 51(6): 1842 - 1850.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Schlosser, M. Strebelow, R. Wassmuth, M.-L. Arnold, I. Breunig, I. Rjasanowski, B. Ziegler, and M. Ziegler
The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of {beta}-Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive Individuals
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2254 - 2261.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. M. LaGasse, M. S. Brantley, N. J. Leech, R. E. Rowe, S. Monks, J. P. Palmer, G. T. Nepom, D. K. McCulloch, and W. A. Hagopian
Successful Prospective Prediction of Type 1 Diabetes in Schoolchildren Through Multiple Defined Autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study
Diabetes Care, March 1, 2002; 25(3): 505 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Knip
Can We Predict Type 1 Diabetes in the General Population?
Diabetes Care, March 1, 2002; 25(3): 623 - 625.
[Full Text] [PDF]

Home page
 DiabetesHome page
A. Kupila, P. Keskinen, T. Simell, S. Erkkila, P. Arvilommi, S. Korhonen, T. Kimpimaki, M. Sjoroos, M. Ronkainen, J. Ilonen, et al.
Genetic Risk Determines the Emergence of Diabetes-Associated Autoantibodies in Young Children
Diabetes, March 1, 2002; 51(3): 646 - 651.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. M. Gillespie, E. A.M. Gale, and P. J. Bingley
High Familial Risk and Genetic Susceptibility in Early Onset Childhood Diabetes
Diabetes, January 1, 2002; 51(1): 210 - 214.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H E WASMUTH, C STOLTE, A GEIER, C GARTUNG, and S MATERN
Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis C
Gut, October 1, 2001; 49(4): 596a - 597.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. M. De Block, I. H. De Leeuw, K. Decochez, F. Winnock, J. Van Autreve, C. M. Van Campenhout, M. Martin, and F. K. Gorus
The Presence of Thyrogastric Antibodies in First Degree Relatives of Type 1 Diabetic Patients Is Associated with Age and Proband Antibody Status
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4358 - 4363.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Yu, D. D. Cuthbertson, N. Maclaren, R. Jackson, J. P. Palmer, T. Orban, G. S. Eisenbarth, and J. P. Krischer
Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies Among Cytoplasmic ICA+ Relatives Is Associated With Eligibility for the Diabetes Prevention Trial-Type 1
Diabetes, August 1, 2001; 50(8): 1735 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Lorini, A. Alibrandi, L. Vitali, C. Klersy, M. Martinetti, C. Betterle, G. d'Annunzio, and E. Bonifacio
Risk of Type 1 Diabetes Development in Children With Incidental Hyperglycemia: A multicenter Italian study
Diabetes Care, July 1, 2001; 24(7): 1210 - 1216.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
G. Byrnes, C C Patterson, G Dahlquist, G Soltesz, A. J Gunn, W. S Cutfield, P. L Hofman, C. Jeferries, L. C. Stene, G. Joner, et al.
Maternal age and risk of type 1 diabetes in children
BMJ, June 16, 2001; 322(7300): 1489 - 1489.
[Full Text]

Home page
 Clin. Chem.Home page
M. Rickert, J. Seissler, W. Dangel, H. Lorenz, and W. Richter
Fusion Proteins for Combined Analysis of Autoantibodies to the 65-kDa Isoform of Glutamic Acid Decarboxylase and Islet Antigen-2 in Insulin-dependent Diabetes Mellitus
Clin. Chem., May 1, 2001; 47(5): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Brooks-Worrell, V. H. Gersuk, C. Greenbaum, and J. P. Palmer
Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes
J. Immunol., April 15, 2001; 166(8): 5265 - 5270.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. J. K. Williams, A. J. Norcross, R. J. Lock, D. J. Unsworth, E. A. M. Gale, and P. J. Bingley
The High Prevalence of Autoantibodies to Tissue Transglutaminase in First-Degree Relatives of Patients With Type 1 Diabetes Is Not Associated With Islet Autoimmunity
Diabetes Care, March 1, 2001; 24(3): 504 - 509.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
P. Kulmala, J. Rahko, K. Savola, P. Vähäsalo, M. Sjöroos, A. Reunanen, J. Ilonen, and M. Knip
{beta}-Cell Autoimmunity, Genetic Susceptibility, and Progression to Type 1 Diabetes in Unaffected Schoolchildren
Diabetes Care, January 1, 2001; 24(1): 171-a - 173.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A.-M. HÄmäläinen, M. S. Ronkainen, H. K. Åkerblom, and M. Knip The Finnish TRIGR Study Group
Postnatal Elimination of Transplacentally Acquired Disease-Associated Antibodies in Infants Born to Families with Type 1 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4249 - 4253.
[Abstract] [Full Text]

Home page
 NEJMHome page
M. C. Honeyman, B. S. Coulson, L. C. Harrison, S. Tanaka, T. Kobayashi, T. Momotsu, A. Imagawa, J.-i. Miyagawa, and T. Hanafusa
A Novel Subtype of Type 1 Diabetes Mellitus
N. Engl. J. Med., June 15, 2000; 342(24): 1835 - 1837.
[Full Text]

Home page
 Clin. Chem.Home page
M. R. Batstra, A. van Driel, J. S. Petersen, C. A. van Donselaar, M. J. van Tol, G. J. Bruining, D. E. Grobbee, T. Dyrberg, and H.-J. Aanstoot
Glutamic Acid Decarboxylase Antibodies in Screening for Autoimmune Diabetes: Influence of Comorbidity, Age, and Sex on Specificity and Threshold Values
Clin. Chem., December 1, 1999; 45(12): 2269 - 2272.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. Mrena, K. Savola, P. Kulmala, H. K. Åkerblom, M. Knip, and the Childhood Diabetes in Finland Study Group
Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children
Pediatrics, October 1, 1999; 104(4): 925 - 930.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
A. Lernmark
Type 1 Diabetes
Clin. Chem., August 1,&nbs